Valor202020212022202320242025TTMFlujo de caja de las actividades de inversión-121.72 M495.41 M-1.05 B-165.8 M755.56 M69.64 M69.64 MFlujo de caja de las actividades financieras682.32 M561.57 M232.51 M125 M124.81 M-168.34 M-168.34 MFlujo de caja libre25.26 M-481.66 M-356.17 M-588.34 M-352.74 M-315.33 M-315.33 M
Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.